Skip to main content
Article
Impact of geodemographic factors on antibiotic prescribing for acute, uncomplicated bronchitis or upper respiratory tract infection
Journal of the American Board of Family Medicine : JABFM
  • Thomas J Dilworth, Advocate Aurora Health
  • Kayla Hietpas, Advocate Aurora Health
  • Jessica J Kram, Advocate Aurora Health
  • Dennis Baumgardner, Advocate Aurora Health
Affiliations

Advocate Aurora Research Institute, Aurora Sinai Medical Center, Aurora UW Medical Group, Aurora St. Luke's Medical Center

Scholarly Activity Date
7-1-2022
Abstract

Objective: To assess the impact of geodemographic factors on antibiotic prescribing for adult acute, uncomplicated bronchitis or upper respiratory tract infection.

Methods: A retrospective, observational study of 63,051 single health-system, outpatient discharges with a primary diagnosis of bronchitis or upper respiratory tract infection in 2019. Univariate analyses of prescribing predictors and multivariable stepwise logistic modeling were performed.

Results: Patients who were older (aOR 1.02; 95% CI 1.02, 1.02), male (1.10; 1.06, 1.14), black (1.29; 1.22, 1.38), smoked (1.18; 1.14, 1.23), seen in urgent care (1.26; 1.22, 1.31) and living in an area with more owner-occupied housing (1.41; 1.30, 1.53) were more likely to receive antibiotics. Patients who were Asian (0.88; 0.77, 0.99), had Medicare (0.83; 0.78, 0.87), Medicaid (0.84; 0.79, 0.87) or Exchange insurance (0.90; 0.82, 0.98), or seen in the emergency department (0.43; 0.40, 0.46) were less likely to receive antibiotics. Distance from a patient's address and their encounter location did not predict antibiotic prescribing.

Conclusions: Antibiotic prescribing interventions for adult acute bronchitis and upper respiratory tract infections could target patients living in an area with higher socioeconomic status.

Type
Article
PubMed ID
35896475
Citation Information

Dilworth TJ, Hietpas K, Kram JJF, Baumgardner D. Impact of Geodemographic Factors on Antibiotic Prescribing for Acute, Uncomplicated Bronchitis or Upper Respiratory Tract Infection. J Am Board Fam Med. 2022;35(4):733-741. doi:10.3122/jabfm.2022.04.210452